Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating a new device for aortic repair

Official title: Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.

Run by University Hospital Muenster · NCT06059053 · Data updated 2026-11-12

This study is testing a new custom-made device for repairing certain aortic problems to see if it works well and is easy to use for patients needing this treatment.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital Muenster
Academic / other
Locations1 site (Münster)
StatusRecruiting
StartedJanuary 12, 2024
Main results expectedDecember 31, 2026
Study endsMarch 31, 2027
Registry record updatedMarch 26, 2024
Trial IDNCT06059053 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with pararenal or thoracoabdominal aortic pathologies who are scheduled for treatment with the semibranch device.

Probably not a fit

Patients under 18 years old and women of childbearing age will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to assess the effectiveness of a custom-made semibranch device in branched endovascular aortic repair for patients with pararenal and thoracoabdominal aortic pathologies. It will evaluate the patency of the semibranch and the feasibility of the technique concerning cannulation and stent grafting. Participants will be treated with the semibranch device and enrolled in the registry upon consent, with no changes to their treatment plan during the study.

Why it matters

Potential benefit: If successful, this could improve outcomes for patients undergoing endovascular aortic repair.

How similar studies have gone: While this approach is novel, similar studies in endovascular aortic repair have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* Presence of pararenal or thoracoabdominal aortic pathology
* Treatment planned a semibranch device branch from Artivion
* Availability of the patients during the follow up period
* Informing patients about the study and providing written informed consent

Exclusion Criteria:

* Women of childbearing age
* Patients under 18 years

Where it's running

  • Muenster University Hospital
    Münster, Germany
    Recruiting

Study contacts

  • Principal investigator: Alexander Oberhuber, MD,PhD — Department of Vascular and Endovascular Surgery University Hospital Münster
  • Study coordinator: Alexander Oberhuber, MD,PhD
  • Email: alexander.oberhuber@ukmuenster.de
  • Phone: +492518345781

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.